AA Bartolucci

1.6k total citations
20 papers, 861 citations indexed

About

AA Bartolucci is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, AA Bartolucci has authored 20 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in AA Bartolucci's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). AA Bartolucci is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). AA Bartolucci collaborates with scholars based in United States, Indonesia and Bangladesh. AA Bartolucci's co-authors include Emily A. Boohaker, A M Pitts, Theresa P. Pretlow, T G Pretlow, Pamela Kimball, E. David Crawford, Michael E. Miller, Lawrence H. Einhorn, Lee Schacter and Patrick J. Loehrer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

AA Bartolucci

19 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AA Bartolucci United States 12 242 237 222 188 170 20 861
G Paolucci Italy 22 267 1.1× 205 0.9× 129 0.6× 91 0.5× 304 1.8× 90 1.3k
Jun Miyauchi Japan 13 267 1.1× 298 1.3× 164 0.7× 104 0.6× 139 0.8× 40 804
Raphael Levey United States 13 204 0.8× 85 0.4× 175 0.8× 192 1.0× 217 1.3× 15 913
Mark A. Arnesen United States 11 445 1.8× 573 2.4× 121 0.5× 131 0.7× 79 0.5× 12 1.2k
Yasunori Toyoda Japan 16 166 0.7× 114 0.5× 104 0.5× 95 0.5× 262 1.5× 38 817
K Thorling Denmark 15 338 1.4× 806 3.4× 135 0.6× 203 1.1× 267 1.6× 29 1.1k
John Dervenoulas Greece 17 214 0.9× 238 1.0× 82 0.4× 168 0.9× 78 0.5× 56 940
E. Papageorgiou Greece 20 278 1.1× 252 1.1× 77 0.3× 131 0.7× 87 0.5× 48 866
P Coser Italy 15 339 1.4× 324 1.4× 64 0.3× 154 0.8× 116 0.7× 38 914
Razelle Kurzrock United States 18 178 0.7× 329 1.4× 127 0.6× 90 0.5× 49 0.3× 24 1.1k

Countries citing papers authored by AA Bartolucci

Since Specialization
Citations

This map shows the geographic impact of AA Bartolucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AA Bartolucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AA Bartolucci more than expected).

Fields of papers citing papers by AA Bartolucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AA Bartolucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AA Bartolucci. The network helps show where AA Bartolucci may publish in the future.

Co-authorship network of co-authors of AA Bartolucci

This figure shows the co-authorship network connecting the top 25 collaborators of AA Bartolucci. A scholar is included among the top collaborators of AA Bartolucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AA Bartolucci. AA Bartolucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alarcón, G S & AA Bartolucci. (2000). Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline.. PubMed. 27(2). 530–4. 11 indexed citations
2.
Sun, Mengxing, BA Gower, Tim R. Nagy, AA Bartolucci, & MI Goran. (1999). Do hormonal indices of maturation explain energy expenditure differences in African American and Caucasian prepubertal children?. International Journal of Obesity. 23(12). 1320–1326. 5 indexed citations
3.
Bae, Sejong, et al.. (1999). Estimation of transition rates in a multi-state proportional hazards model. Environment International. 25(6-7). 781–785. 1 indexed citations
4.
Loeffler, Markus, Oana Brosteanu, Dirk Hasenclever, et al.. (1998). Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.. Journal of Clinical Oncology. 16(3). 818–829. 143 indexed citations
5.
Heimburger, Douglas C., et al.. (1996). Randomized trial of tolerance and efficacy of a small-peptide enteral feeding formula versus a whole-protein formula.. PubMed. 11(4). 360–4. 11 indexed citations
6.
Nichols, Craig R., Stephen D. Williams, Patrick J. Loehrer, et al.. (1991). Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.. Journal of Clinical Oncology. 9(7). 1163–1172. 204 indexed citations
7.
Chlebowski, R. T., et al.. (1989). Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. British Journal of Cancer. 59(2). 227–230. 32 indexed citations
8.
Cohen, HJ, AA Bartolucci, Walter B. Forman, & H Silberman. (1986). Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment.. Journal of Clinical Oncology. 4(6). 888–899. 20 indexed citations
9.
Forman, Walter B., et al.. (1984). Phase II evaluation of chlorozotocin in refractory multiple myeloma.. PubMed. 68(11). 1409–10. 2 indexed citations
12.
Presant, Cary A., Richard A. Gams, & AA Bartolucci. (1984). Treatment of metastatic sarcomas with mitoxantrone.. PubMed. 68(5). 813–4. 7 indexed citations
13.
Crist, WM, et al.. (1983). Monoclonal antibody characterization of surface antigens in childhood T- cell lymphoid malignancies. Blood. 61(5). 830–837. 6 indexed citations
14.
Röper, M, WM Crist, Richard S. Metzgar, et al.. (1983). Monoclonal antibody characterization of surface antigens in childhood T- cell lymphoid malignancies. Blood. 61(5). 830–837. 105 indexed citations
15.
Pretlow, Theresa P., et al.. (1983). Cytologic characterization of pulmonary alveolar macrophages by enzyme histochemistry in plastic.. Journal of Histochemistry & Cytochemistry. 31(12). 1412–1418. 31 indexed citations
16.
Pretlow, Theresa P., AA Bartolucci, A M Pitts, et al.. (1983). Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.. PubMed. 43(6). 2997–3000. 171 indexed citations
17.
Nathwani, BN, et al.. (1983). Malignant lymphoma, mixed cell type, diffuse. Blood. 62(1). 200–208. 22 indexed citations
18.
Nathwani, BN, et al.. (1983). Malignant lymphoma, mixed cell type, diffuse. Blood. 62(1). 200–208. 2 indexed citations
19.
Crist, WM, DJ Pullen, AA Bartolucci, et al.. (1981). An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia. Blood. 58(1). 135–140. 3 indexed citations
20.
Crist, WM, DJ Pullen, AA Bartolucci, et al.. (1981). An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia. Blood. 58(1). 135–140. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026